{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:51:33Z","timestamp":1776693093310,"version":"3.51.2"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project of High-Level Talents in AHUCM","award":["2022rczd013"],"award-info":[{"award-number":["2022rczd013"]}]},{"name":"Provincial college student innovation and entrepreneurship training program","award":["S202310369142"],"award-info":[{"award-number":["S202310369142"]}]},{"name":"Natural Science Research Project of Anhui Educational Committee","award":["2023AH050792"],"award-info":[{"award-number":["2023AH050792"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Nonalcoholic steatohepatitis (NASH) is a progressive manifestation of nonalcoholic fatty liver disease (NAFLD) that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Despite the growing knowledge of NASH and HCC, the association between the two conditions remains to be fully explored. Bioinformatics has emerged as a valuable approach for identifying disease-specific feature genes, enabling advancements in disease prediction, prevention, and personalized treatment strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>In this study, we utilized CellChat, copy number karyotyping of aneuploid tumors (CopyKAT), consensus Non-negative Matrix factorization (cNMF), Gene set enrichment analysis (GSEA), Gene set variation analysis (GSVA), Monocle, spatial co-localization, single sample gene set enrichment analysis (ssGSEA), Slingshot, and the Scissor algorithm to analyze the cellular and immune landscape of NASH and HCC. Through the Scissor algorithm, we identified three cell types correlating with disease phenotypic features and subsequently developed a novel clinical prediction model using univariate, LASSO, and multifactor Cox regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results revealed that macrophages are a significant pathological factor in the development of NASH and HCC and that the macrophage migration inhibitory factor (MIF) signaling pathway plays a crucial role in cellular crosstalk at the molecular level. We deduced three prognostic genes (YBX1, MED8, and KPNA2), demonstrating a strong diagnostic capability in both NASH and HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings shed light on the pathological mechanisms shared between NASH and HCC, providing valuable insights for the development of novel clinical strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-024-04885-6","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T10:02:20Z","timestamp":1705572140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuan","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoqing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"4885_CR1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158:1851\u201364.","journal-title":"Gastroenterology"},{"key":"4885_CR2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","volume":"26","author":"S Raza","year":"2021","unstructured":"Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front Biosci (Landmark Ed). 2021;26:206\u201337.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4885_CR3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.21037\/atm-20-3760","volume":"9","author":"E Roeb","year":"2021","unstructured":"Roeb E. Non-alcoholic fatty liver diseases: current challenges and future directions. Ann Transl Med. 2021;9:726.","journal-title":"Ann Transl Med"},{"key":"4885_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","volume":"68","author":"PK Santhekadur","year":"2018","unstructured":"Santhekadur PK, Kumar DP, Sanyal AJ. Preclinical models of non-alcoholic fatty liver disease. J Hepatol. 2018;68:230\u20137.","journal-title":"J Hepatol"},{"key":"4885_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","volume":"16","author":"AJ Sanyal","year":"2019","unstructured":"Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2019;16:377\u201386.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4885_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","volume":"20","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenw\u00e4lder M, El-Serag HB, Finn RS, Friedman SL. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20:487\u2013503.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4885_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2023.04.010","volume":"93","author":"SA Polyzos","year":"2023","unstructured":"Polyzos SA, Chrysavgis L, Vachliotis ID, Chartampilas E, Cholongitas E. Nonalcoholic fatty liver disease and hepatocellular carcinoma: Insights in epidemiology, pathogenesis, imaging, prevention and therapy. Semin Cancer Biol. 2023;93:20\u201335.","journal-title":"Semin Cancer Biol"},{"key":"4885_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","volume":"20","author":"LA Orci","year":"2022","unstructured":"Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, Bruix J, Reig M, Toso C. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Clin Gastroenterol Hepatol. 2022;20:283-292.e210.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4885_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4885_CR10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, N\u00fa\u00f1ez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, Gupta R, Qiu M, Deczkowska A, Weiner A, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592:450\u20136.","journal-title":"Nature"},{"key":"4885_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","volume":"74","author":"O Kucukoglu","year":"2021","unstructured":"Kucukoglu O, Sowa JP, Mazzolini GD, Syn WK, Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol. 2021;74:442\u201357.","journal-title":"J Hepatol"},{"key":"4885_CR12","doi-asserted-by":"crossref","first-page":"eadh0831","DOI":"10.1126\/sciadv.adh0831","volume":"9","author":"E Boslem","year":"2023","unstructured":"Boslem E, Reibe S, Carlessi R, Smeuninx B, Tegegne S, Egan CL, McLennan E, Terry LV, Nobis M, Mu A, et al. Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC. Sci Adv. 2023;9:eadh0831.","journal-title":"Sci Adv"},{"key":"4885_CR13","volume":"10","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang Q, Teng D, Guo M, Tang K, Wang Z, Wei X, Lin L, Zhang X, Wang X, et al. FGF9 recruits \u03b2-catenin to increase hepatic ECM synthesis and promote NASH-driven HCC. Adv Sci (Weinh). 2023;10: e2301166.","journal-title":"Adv Sci (Weinh)"},{"key":"4885_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"4885_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cancers15010023","volume":"15","author":"J Guti\u00e9rrez-Cuevas","year":"2022","unstructured":"Guti\u00e9rrez-Cuevas J, Lucano-Landeros S, L\u00f3pez-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies. Cancers (Basel). 2022;15:23.","journal-title":"Cancers (Basel)"},{"key":"4885_CR16","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371: m3544.","journal-title":"BMJ"},{"key":"4885_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","volume":"149","author":"E Dhamija","year":"2019","unstructured":"Dhamija E, Paul SB, Kedia S. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern. Indian J Med Res. 2019;149:9\u201317.","journal-title":"Indian J Med Res"},{"key":"4885_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/HMER.S278076","volume":"13","author":"J Neuberger","year":"2021","unstructured":"Neuberger J, Cain O. The need for alternatives to liver biopsies: non-invasive analytics and diagnostics. Hepat Med. 2021;13:59\u201369.","journal-title":"Hepat Med"},{"key":"4885_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","volume":"29","author":"MA Febbraio","year":"2019","unstructured":"Febbraio MA, Reibe S, Shalapour S, Ooi GJ, Watt MJ, Karin M. Preclinical models for studying NASH-driven HCC: how useful are they? Cell Metab. 2019;29:18\u201326.","journal-title":"Cell Metab"},{"key":"4885_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41575-020-0304-x","volume":"17","author":"P Ramachandran","year":"2020","unstructured":"Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol. 2020;17:457\u201372.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4885_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050905","author":"YM Chen","year":"2022","unstructured":"Chen YM, Lian CF, Sun QW, Wang TT, Liu YY, Ye J, Gao LL, Yang YF, Liu SN, Shen ZF, Liu YL. Ramulus Mori (Sangzhi) alkaloids alleviate high-fat diet-induced obesity and nonalcoholic fatty liver disease in mice. Antioxidants (Basel). 2022. https:\/\/doi.org\/10.3390\/antiox11050905.","journal-title":"Antioxidants (Basel)"},{"key":"4885_CR22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY, Ji Y, Li C, Guo L, et al. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell. 2019;75:644-660.e645.","journal-title":"Mol Cell"},{"key":"4885_CR23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.immuni.2021.04.027","volume":"54","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhangyuan G, Wang F, Jin K, Shen H, Zhang L, Yuan X, Wang J, Zhang H, Yu W, et al. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity. 2021;54:1168-1185.e1168.","journal-title":"Immunity"},{"key":"4885_CR24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell. 2019;36:418-430.e416.","journal-title":"Cancer Cell"},{"key":"4885_CR25","doi-asserted-by":"publisher","unstructured":"Shankar R, Tan MD, Zhang YQ, Green B, Zagorski JW, Goodyke AJ, Paithankar S, Adams M, Hostetter G, Siwicki RA, Hein S, Yang D, Zhou L, Mi QS, Ghaziani TT, Dhanasekaran R, Chesla D, Chen X, Xiao H, So S, Chua MS, Chen B. Spatial transcriptomics in HCC. Zenodo. 2023. https:\/\/doi.org\/10.5281\/zenodo.7785709","DOI":"10.5281\/zenodo.7785709"},{"key":"4885_CR26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","volume":"61","author":"BM Arendt","year":"2015","unstructured":"Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, Fung SK, Wong DK, McGilvray I, Fischer SE, Allard JP. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology. 2015;61:1565\u201378.","journal-title":"Hepatology"},{"key":"4885_CR27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.","journal-title":"Nucleic Acids Res"},{"key":"4885_CR28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"4885_CR29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"4885_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13059-021-02581-y","volume":"23","author":"SC Zheng","year":"2022","unstructured":"Zheng SC, Stein-O\u2019Brien G, Augustin JJ, Slosberg J, Carosso GA, Winer B, Shin G, Bjornsson HT, Goff LA, Hansen KD. Universal prediction of cell-cycle position using transfer learning. Genome Biol. 2022;23:41.","journal-title":"Genome Biol"},{"key":"4885_CR31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"4885_CR32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43803","volume":"8","author":"D Kotliar","year":"2019","unstructured":"Kotliar D, Veres A, Nagy MA, Tabrizi S, Hodis E, Melton DA, Sabeti PC. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife. 2019;8: e43803.","journal-title":"Elife"},{"key":"4885_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.","journal-title":"BMC Bioinform"},{"key":"4885_CR34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The immune landscape of cancer. Immunity. 2018;48:812-830.e814.","journal-title":"Immunity"},{"key":"4885_CR35","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"4885_CR36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14:979\u201382.","journal-title":"Nat Methods"},{"key":"4885_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, Ilagan F, Kuo AH, Hsieh RW, Cai S, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367:405\u201311.","journal-title":"Science"},{"key":"4885_CR38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, Purdom E, Dudoit S. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018;19:477.","journal-title":"BMC Genomics"},{"key":"4885_CR39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:296.","journal-title":"Genome Biol"},{"key":"4885_CR40","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1101\/gr.276851.122","volume":"32","author":"Q Liu","year":"2022","unstructured":"Liu Q, Hsu CY, Shyr Y. Scalable and model-free detection of spatial patterns and colocalization. Genome Res. 2022;32:1736\u201345.","journal-title":"Genome Res"},{"key":"4885_CR41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792-809.e723.","journal-title":"Cell"},{"key":"4885_CR42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"4885_CR43","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, Qian X, Wang M, He X, Wang T, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1: e36.","journal-title":"iMeta"},{"key":"4885_CR44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829-845.e820.","journal-title":"Cell"},{"key":"4885_CR45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77974","volume":"11","author":"LK Krasniewski","year":"2022","unstructured":"Krasniewski LK, Chakraborty P, Cui CY, Mazan-Mamczarz K, Dunn C, Piao Y, Fan J, Shi C, Wallace T, Nguyen C, et al. Single-cell analysis of skeletal muscle macrophages reveals age-associated functional subpopulations. Elife. 2022;11: e77974.","journal-title":"Elife"},{"key":"4885_CR46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.994480","volume":"13","author":"M Flores Molina","year":"2022","unstructured":"Flores Molina M, Abdelnabi MN, Mazouz S, Villafranca-Baughman D, Trinh VQ, Muhammad S, B\u00e9dard N, Osorio Laverde D, Hassan GS, Di Polo A, Shoukry NH. Distinct spatial distribution and roles of Kupffer cells and monocyte-derived macrophages in mouse acute liver injury. Front Immunol. 2022;13: 994480.","journal-title":"Front Immunol"},{"key":"4885_CR47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","volume":"34","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen Z, Kuang H, Liu T, Zhu J, Zhou L, Wang Q, Xiong X, Meng Z, Qiu X, et al. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metab. 2022;34:1359-1376.e1357.","journal-title":"Cell Metab"},{"key":"4885_CR48","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Wang M, Guo H, Hou J, Zhang Y, Li M, Wu X, Chen X, Wang L. Integrated analysis highlights the immunosuppressive role of TREM2(+) macrophages in hepatocellular carcinoma. Front Immunol. 2022;13: 848367.","journal-title":"Front Immunol"},{"key":"4885_CR49","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364.","journal-title":"Cell"},{"key":"4885_CR50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","volume":"28","author":"L Chrysavgis","year":"2022","unstructured":"Chrysavgis L, Giannakodimos I, Diamantopoulou P, Cholongitas E. Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link. World J Gastroenterol. 2022;28:310\u201331.","journal-title":"World J Gastroenterol"},{"key":"4885_CR51","volume":"1877","author":"XY Li","year":"2022","unstructured":"Li XY, Shen Y, Zhang L, Guo X, Wu J. Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing. Biochim Biophys Acta Rev Cancer. 2022;1877: 188720.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4885_CR52","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1038\/s41598-021-98806-y","volume":"11","author":"ZY Wang","year":"2021","unstructured":"Wang ZY, Keogh A, Waldt A, Cuttat R, Neri M, Zhu S, Schuierer S, Ruchti A, Crochemore C, Knehr J, et al. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Sci Rep. 2021;11:19396.","journal-title":"Sci Rep"},{"key":"4885_CR53","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1038\/s41598-022-16754-7","volume":"12","author":"RG Fred","year":"2022","unstructured":"Fred RG, Steen Pedersen J, Thompson JJ, Lee J, Timshel PN, Stender S, Opseth Rygg M, Gluud LL, Bjerregaard Kristiansen V, Bendtsen F, et al. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Sci Rep. 2022;12:13484.","journal-title":"Sci Rep"},{"key":"4885_CR54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131.","journal-title":"Mol Cancer"},{"key":"4885_CR55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren X, Zhang L, Zhang Y, Li Z, Siemers N, Zhang Z. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annu Rev Immunol. 2021;39:583\u2013609.","journal-title":"Annu Rev Immunol"},{"key":"4885_CR56","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology. 2023;77:1773\u201396.","journal-title":"Hepatology"},{"key":"4885_CR57","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/biomedicines9111598","volume":"9","author":"C Lee","year":"2021","unstructured":"Lee C, Kim M, Han J, Yoon M, Jung Y. Mesenchymal stem cells influence activation of hepatic stellate cells, and constitute a promising therapy for liver fibrosis. Biomedicines. 2021;9:1598.","journal-title":"Biomedicines"},{"key":"4885_CR58","doi-asserted-by":"crossref","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177.","journal-title":"Front Oncol"},{"key":"4885_CR59","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.3390\/ijms231810777","volume":"23","author":"PW Wang","year":"2022","unstructured":"Wang PW, Lin TY, Yang PM, Yeh CT, Pan TL. Hepatic stellate cell modulates the immune microenvironment in the progression of hepatocellular carcinoma. Int J Mol Sci. 2022;23:10777.","journal-title":"Int J Mol Sci"},{"key":"4885_CR60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.31743","volume":"74","author":"SB Rosenthal","year":"2021","unstructured":"Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, Li RZ, Troutman TD, Kisseleva T, Glass CK, Brenner DA. Heterogeneity of HSCs in a mouse model of NASH. Hepatology. 2021;74:667\u201385.","journal-title":"Hepatology"},{"key":"4885_CR61","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","volume":"158","author":"X Liu","year":"2020","unstructured":"Liu X, Xu J, Rosenthal S, Zhang LJ, McCubbin R, Meshgin N, Shang L, Koyama Y, Ma HY, Sharma S, et al. Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution. Gastroenterology. 2020;158:1728-1744.e1714.","journal-title":"Gastroenterology"},{"key":"4885_CR62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, Bhattacharjee S, Affo S, Fujiwara N, Su H, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022;610:356\u201365.","journal-title":"Nature"},{"key":"4885_CR63","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.743907","volume":"9","author":"P Manoukian","year":"2021","unstructured":"Manoukian P, Bijlsma M, van Laarhoven H. The cellular origins of cancer-associated fibroblasts and their opposing contributions to pancreatic cancer growth. Front Cell Dev Biol. 2021;9: 743907.","journal-title":"Front Cell Dev Biol"},{"key":"4885_CR64","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146987","volume":"131","author":"S Bhattacharjee","year":"2021","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest. 2021;131: e146987.","journal-title":"J Clin Invest"},{"key":"4885_CR65","doi-asserted-by":"crossref","first-page":"12061","DOI":"10.18632\/oncotarget.3616","volume":"6","author":"T Song","year":"2015","unstructured":"Song T, Dou C, Jia Y, Tu K, Zheng X. TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1\/CXCR4 signaling in hepatocellular carcinoma. Oncotarget. 2015;6:12061\u201379.","journal-title":"Oncotarget"},{"key":"4885_CR66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2017.12.021","volume":"417","author":"Q Luo","year":"2018","unstructured":"Luo Q, Wang CQ, Yang LY, Gao XM, Sun HT, Zhang Y, Zhang KL, Zhu Y, Zheng Y, Sheng YY, et al. FOXQ1\/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells. Cancer Lett. 2018;417:21\u201334.","journal-title":"Cancer Lett"},{"key":"4885_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071723","author":"J Baglieri","year":"2019","unstructured":"Baglieri J, Brenner DA, Kisseleva T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20071723.","journal-title":"Int J Mol Sci"},{"key":"4885_CR68","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u20139.","journal-title":"Nat Immunol"},{"key":"4885_CR69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","volume":"77","author":"M Barsch","year":"2022","unstructured":"Barsch M, Sali\u00e9 H, Schlaak AE, Zhang Z, Hess M, Mayer LS, Tauber C, Otto-Mora P, Ohtani T, Nilsson T, et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol. 2022;77:397\u2013409.","journal-title":"J Hepatol"},{"key":"4885_CR70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","volume":"66","author":"M Garnelo","year":"2017","unstructured":"Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66:342\u201351.","journal-title":"Gut"},{"key":"4885_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1312-y","author":"RR Yao","year":"2018","unstructured":"Yao RR, Li JH, Zhang R, Chen RX, Wang YH. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4\/STAT3 signaling pathway. World J Surg Oncol. 2018. https:\/\/doi.org\/10.1186\/s12957-018-1312-y.","journal-title":"World J Surg Oncol"},{"key":"4885_CR72","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.29681","volume":"67","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Q, Lou Y, Fu Q, Chen Q, Wei T, Yang J, Tang J, Wang J, Chen Y, et al. Hypoxia-inducible factor-1\u03b1\/interleukin-1\u03b2 signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Hepatology. 2018;67:1872\u201389.","journal-title":"Hepatology"},{"key":"4885_CR73","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2014.2761","volume":"46","author":"XT Fu","year":"2015","unstructured":"Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ, Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB, Fan J. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/Snail pathway. Int J Oncol. 2015;46:587\u201396.","journal-title":"Int J Oncol"},{"key":"4885_CR74","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","volume":"3","author":"T Calandra","year":"2003","unstructured":"Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791\u2013800.","journal-title":"Nat Rev Immunol"},{"key":"4885_CR75","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108024","volume":"233","author":"K Sumaiya","year":"2022","unstructured":"Sumaiya K, Langford D, Natarajaseenivasan K, Shanmughapriya S. Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther. 2022;233: 108024.","journal-title":"Pharmacol Ther"},{"key":"4885_CR76","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.1107023108","volume":"108","author":"D Heinrichs","year":"2011","unstructured":"Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C, et al. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci U S A. 2011;108:17444\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4885_CR77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/JOE-13-0135","volume":"218","author":"HY Moon","year":"2013","unstructured":"Moon HY, Song P, Choi CS, Ryu SH, Suh PG. Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease. J Endocrinol. 2013;218:339\u201348.","journal-title":"J Endocrinol"},{"key":"4885_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020252","author":"D Heinrichs","year":"2021","unstructured":"Heinrichs D, Brandt EF, Fischer P, K\u00f6hncke J, Wirtz TH, Guldiken N, Djudjaj S, Boor P, Kroy D, Weiskirchen R, et al. Unexpected pro-fibrotic effect of MIF in non-alcoholic steatohepatitis is linked to a shift in NKT Cell populations. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10020252.","journal-title":"Cells"},{"key":"4885_CR79","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.drudis.2018.06.017","volume":"23","author":"T Kok","year":"2018","unstructured":"Kok T, Wasiel AA, Cool RH, Melgert BN, Poelarends GJ, Dekker FJ. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders. Drug Discov Today. 2018;23:1910\u20138.","journal-title":"Drug Discov Today"},{"key":"4885_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16257","author":"B Gy\u0151rffy","year":"2023","unstructured":"Gy\u0151rffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2023. https:\/\/doi.org\/10.1111\/bph.16257.","journal-title":"Br J Pharmacol"},{"key":"4885_CR81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.34265","volume":"152","author":"B Kim","year":"2023","unstructured":"Kim B, Jung M, Moon KC, Han D, Kim K, Kim H, Yang S, Lee D, Jun H, Lee KM, et al. Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer. Int J Cancer. 2023;152:320\u201330.","journal-title":"Int J Cancer"},{"key":"4885_CR82","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15384101.2021.1903208","volume":"20","author":"M Cui","year":"2021","unstructured":"Cui M, Zhao Y, Zhang Z, Zhao Y, Han S, Wang R, Ding D, Fang X. IL-8, MSPa, MIF, FGF-9, ANG-2 and AgRP collection were identified for the diagnosis of colorectal cancer based on the support vector machine model. Cell Cycle. 2021;20:781\u201391.","journal-title":"Cell Cycle"},{"key":"4885_CR83","volume":"12","author":"X Jin","year":"2022","unstructured":"Jin X, Song Y, An Z, Wu S, Cai D, Fu Y, Zhang C, Chen L, Tang W, Zheng Z, et al. A predictive model for prognosis and therapeutic response in hepatocellular carcinoma based on a panel of three MED8-related immunomodulators. Front Oncol. 2022;12: 868411.","journal-title":"Front Oncol"},{"key":"4885_CR84","first-page":"1765","volume":"14","author":"S Wu","year":"2022","unstructured":"Wu S, Li Q, Cao Y, Luo S, Wang Z, Zhang T. Mediator complex subunit 8 is a prognostic biomarker in hepatocellular carcinoma. Am J Transl Res. 2022;14:1765\u201377.","journal-title":"Am J Transl Res"},{"key":"4885_CR85","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijbiomac.2022.08.100","volume":"220","author":"A Chaudhary","year":"2022","unstructured":"Chaudhary A, Chaurasia PK, Kushwaha S, Chauhan P, Chawade A, Mani A. Correlating multi-functional role of cold shock domain proteins with intrinsically disordered regions. Int J Biol Macromol. 2022;220:743\u201353.","journal-title":"Int J Biol Macromol"},{"key":"4885_CR86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng M, Xie X, Han G, Zhang T, Li Y, Li Y, Yin R, Wang Q, Zhang T, Wang P, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138:71\u201385.","journal-title":"Blood"},{"key":"4885_CR87","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang X, Wang L, Kang C, Li N, Xiao Z, Dai L. Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma. PeerJ. 2021;9: e12197.","journal-title":"PeerJ"},{"key":"4885_CR88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/abbs\/gmz003","volume":"51","author":"X Guo","year":"2019","unstructured":"Guo X, Wang Z, Zhang J, Xu Q, Hou G, Yang Y, Dong C, Liu G, Liang C, Liu L, et al. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types. Acta Biochim Biophys Sin (Shanghai). 2019;51:285\u201392.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4885_CR89","first-page":"2815","volume":"15","author":"CL Gao","year":"2018","unstructured":"Gao CL, Wang GW, Yang GQ, Yang H, Zhuang L. Karyopherin subunit-\u03b1 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma. Oncol Lett. 2018;15:2815\u201320.","journal-title":"Oncol Lett"},{"key":"4885_CR90","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1080\/21655979.2022.2049472","volume":"13","author":"G Tang","year":"2022","unstructured":"Tang G, Zhao H, Xie Z, Wei S, Chen G. Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin \u03b12 (KPNA2) and inactivate p53 signaling. Bioengineered. 2022;13:7829\u201346.","journal-title":"Bioengineered"},{"key":"4885_CR91","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41419-021-04449-2","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Liu R, Niu Y, Mo H, Wang H, Lu Y, Wang L, Sun L, Wang Y, Tu K, Liu Q. HIF-1\u03b1-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p\/KPNA2\/AKT pathway. Cell Death Dis. 2021;12:1152.","journal-title":"Cell Death Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-04885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-04885-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-04885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T10:04:00Z","timestamp":1705572240000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-04885-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4885"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-04885-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All datasets used in this study have been previously published. The patients and animals involved obtained ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}